Reinhard Ebner

8.3k total citations · 4 hit papers
27 papers, 6.9k citations indexed

About

Reinhard Ebner is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Reinhard Ebner has authored 27 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Reinhard Ebner's work include TGF-β signaling in diseases (6 papers), Cancer Cells and Metastasis (4 papers) and 3D Printing in Biomedical Research (4 papers). Reinhard Ebner is often cited by papers focused on TGF-β signaling in diseases (6 papers), Cancer Cells and Metastasis (4 papers) and 3D Printing in Biomedical Research (4 papers). Reinhard Ebner collaborates with scholars based in United States, Germany and Slovakia. Reinhard Ebner's co-authors include Leoni A. Kunz‐Schughart, Claudia Seidel, Jian Ni, Rik Derynck, Vishva M. Dixit, Arul M. Chinnaiyan, Karen O’Rourke, Reiner Gentz, Guohua Pan and Ruey‐Hwa Chen and has published in prestigious journals such as Science, Journal of Biological Chemistry and Immunity.

In The Last Decade

Reinhard Ebner

27 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Receptor for the Cytotoxic Ligand TRAIL

1997 1.5k citations Guohua Pan, Karen O’Rourke et al. Science profile →
Spheroid-based drug screen: considerations and practical approach

2009 1.4k citations Claudia Seidel, Reinhard Ebner et al. Nature Protocols profile →
LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator

1998 665 citations Davide Mauri, Reinhard Ebner et al. Immunity profile →
The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model

2004 610 citations Leoni A. Kunz‐Schughart, James P. Freyer et al. SLAS DISCOVERY profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reinhard Ebner United States	22	3.5k	2.1k	1.8k	1.5k	1.1k	27	6.9k
In‐San Kim South Korea	50	4.6k 1.3×	1.0k 0.5×	1.5k 0.9×	1.2k 0.8×	1.5k 1.4×	166	7.7k
Shulin Li United States	46	3.9k 1.1×	2.7k 1.3×	2.0k 1.1×	981 0.7×	1.4k 1.3×	207	8.6k
Silvana Canevari Italy	49	4.4k 1.3×	3.2k 1.6×	2.2k 1.3×	651 0.4×	1.4k 1.3×	227	8.7k
Lei Yao China	42	3.2k 0.9×	1.6k 0.8×	1.3k 0.7×	700 0.5×	1.1k 1.1×	151	6.5k
Yong Teng United States	41	3.7k 1.1×	1.3k 0.6×	909 0.5×	965 0.7×	1.5k 1.4×	178	6.4k
Vicki Plaks United States	24	3.5k 1.0×	3.3k 1.6×	1.6k 0.9×	1.2k 0.8×	2.4k 2.3×	52	8.1k
Nicole Beauchemin Canada	42	2.9k 0.8×	1.7k 0.8×	1.5k 0.8×	806 0.6×	341 0.3×	114	6.6k
Vyomesh Patel United States	50	5.7k 1.6×	1.9k 0.9×	657 0.4×	2.2k 1.5×	1.1k 1.1×	111	9.1k
Curzio Rüegg Switzerland	45	3.0k 0.9×	2.2k 1.1×	1.8k 1.0×	408 0.3×	1.3k 1.2×	132	6.4k
Timo L.M. ten Hagen Netherlands	49	3.6k 1.1×	1.8k 0.9×	1.4k 0.8×	3.1k 2.1×	899 0.8×	212	8.8k

Countries citing papers authored by Reinhard Ebner

Since Specialization

Citations

This map shows the geographic impact of Reinhard Ebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reinhard Ebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reinhard Ebner more than expected).

Fields of papers citing papers by Reinhard Ebner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reinhard Ebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reinhard Ebner. The network helps show where Reinhard Ebner may publish in the future.

Co-authorship network of co-authors of Reinhard Ebner

This figure shows the co-authorship network connecting the top 25 collaborators of Reinhard Ebner. A scholar is included among the top collaborators of Reinhard Ebner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reinhard Ebner. Reinhard Ebner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spitzner, Melanie, Reinhard Ebner, Hendrik A. Wolff, et al.. (2014). STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy. Cancers. 6(4). 1986–2011. 79 indexed citations

Spitzner, Melanie, Georg Emons, Jochen Gaedcke, et al.. (2013). STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo. International Journal of Cancer. 134(4). 997–1007. 107 indexed citations

Spitzner, Melanie, Margret Rave‐Fränk, Georg Emons, et al.. (2011). Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis. 32(12). 1824–1831. 74 indexed citations

Grade, Marian, Amanda B. Hummon, Jordi Camps, et al.. (2010). A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. International Journal of Cancer. 128(5). 1069–1079. 39 indexed citations

Seidel, Claudia, et al.. (2009). Spheroid-based drug screen: considerations and practical approach. Nature Protocols. 4(3). 309–324. 1351 indexed citations breakdown →

Eder, Wolfgang, et al.. (2007). A Reliable Tool to Determine Cell Viability in Complex 3-D Culture: The Acid Phosphatase Assay. SLAS DISCOVERY. 12(7). 925–937. 177 indexed citations

Bol, David K. & Reinhard Ebner. (2006). Gene Expression Profiling in the Discovery, Optimization and Development of Novel Drugs: One Universal Screening Platform. Pharmacogenomics. 7(2). 227–235. 16 indexed citations

Kießling, Andrea, Bernd Weigle, Susanne Fuessel, et al.. (2005). D‐TMPP: A novel androgen‐regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family. The Prostate. 64(4). 387–400. 14 indexed citations

Khalak, Hanif, et al.. (2005). Expression Biomarkers for Clinical Efficacy and Outcome Prediction in Cancer. Pharmacogenomics. 7(1). 105–115. 8 indexed citations

10.

Weigle, Bernd, Reinhard Ebner, Achim Temme, et al.. (2005). Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas. Oncology Reports. 13(1). 139–44. 81 indexed citations

11.

Weigle, Bernd, Andrea Kießling, Reinhard Ebner, et al.. (2004). D‐PCa‐2: A novel transcript highly overexpressed in human prostate and prostate cancer. International Journal of Cancer. 109(6). 882–892. 5 indexed citations

12.

Weigle, Bernd, Susanne Fuessel, Reinhard Ebner, et al.. (2004). D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate. Biochemical and Biophysical Research Communications. 322(1). 239–249. 21 indexed citations

13.

Kunz‐Schughart, Leoni A., James P. Freyer, Ferdinand Hofstaedter, & Reinhard Ebner. (2004). The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model. SLAS DISCOVERY. 9(4). 273–285. 610 indexed citations breakdown →

14.

Shi, Yanggu, Stephen J. Ullrich, Jun Zhang, et al.. (2000). A Novel Cytokine Receptor-Ligand Pair. Journal of Biological Chemistry. 275(25). 19167–19176. 186 indexed citations

15.

Giovarelli, Mirella, Piero Musiani, Gianni Garotta, et al.. (1999). A “Stealth Effect”: Adenocarcinoma Cells Engineered to Express TRAIL Elude Tumor-Specific and Allogeneic T Cell Reactions. The Journal of Immunology. 163(9). 4886–4893. 46 indexed citations

16.

Mauri, Davide, Reinhard Ebner, Rebecca I. Montgomery, et al.. (1998). LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator. Immunity. 8(1). 21–30. 665 indexed citations breakdown →

17.

Gazit, Dan, Yoram Zilberman, Reinhard Ebner, & Arnold Kahn. (1998). Bone loss (osteopenia) in old male mice results from diminished activity and availability of TGF-β. Journal of Cellular Biochemistry. 70(4). 478–488. 41 indexed citations

18.

Pan, Guohua, Karen O’Rourke, Arul M. Chinnaiyan, et al.. (1997). The Receptor for the Cytotoxic Ligand TRAIL. Science. 276(5309). 111–113. 1514 indexed citations breakdown →

19.

Lawler, Sean, Albert F. Candia, Reinhard Ebner, et al.. (1994). The murine type II TGF-β receptor has a coincident embryonic expression and binding preference for TGF-β1. Development. 120(1). 165–175. 74 indexed citations

20.

Chen, Ruey‐Hwa, Reinhard Ebner, & Rik Derynck. (1993). Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β Activities. Science. 260(5112). 1335–1338. 343 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact